Genertec Universal Medical completes RMB250 million second-tranche MTN issuance at 1.73% coupon

Bulletin Express08-26 17:21

Genertec Universal Medical Group Company Limited announced the successful completion of the second tranche of its 2026 domestic medium-term notes (T2 Notes) on 25 August 2026. The issuance was executed through its wholly-owned subsidiary, China Universal Leasing Co., Ltd., and raised the full targeted principal of RMB250 million.

The two-year T2 Notes, commencing 26 August 2026, carry a fixed annual coupon of 1.73% and were priced at par (RMB100.0 per note). The offering follows the board’s approval disclosed on 24 August 2026 and is part of the company’s 2026 medium-term note programme.

Genertec Universal Medical stated that all directors—comprising executive, non-executive and independent non-executive members—were in office as of the announcement date, 26 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment